The Hyundai Cancer Institute at CHOC Blood and Marrow Transplantation (BMT) Program is made up of a team of highly trained oncology experts, including two dedicated nurse coordinators who assist patients and their families through the transplant process. The majority of children who may benefit from a blood or bone marrow transplant are those with leukemia, including acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). Other conditions that may respond to transplantation include hematologic disorders such as immune deficiencies and aplastic anemia, Hodgkin’s and non-Hodgkin’s lymphoma, Ewing’s sarcoma and solid tumors including some brain tumors and neuroblastoma.
The Hyundai Cancer Institute BMT Program is the only pediatric blood and bone marrow transplant program in Orange County and offers a full range of transplant procedures and services, including autologous and allogeneic transplants and cellular immunotherapy. In addition to performing all necessary tests and procedures prior to the transplant, we test immediate family members (siblings and parents) to see if they are a match for the patient.
Specialized Care for Children and Teens
When a child is ill and needs hospitalization, we understand that the entire family is affected. CHOC strongly believes in allowing a child to be a child and creating a sense of normalcy through play, discovery and creativity. That’s why we are dedicated to offering the most comprehensive support programs in the region, so kids don’t have to give up being kids. The Cancer Institute offers patients and families:
- One-of-a-kind hospital experience with child life services, activities, special events and much more.
- Comprehensive diagnostic services.
- Outstanding outpatient services, including a dedicated clinic, outpatient infusion center and radiation therapy center.
- Pediatric cancer second opinions to provide reassurance when making decisions about your child’s care.
- Health features from our oncology experts.
The Latest Treatments and Research
Children’s cancers are very different than adult cancers and must be treated with specific pediatric cancer protocols. Our experience in exclusively treating children, teens and young adults makes us the experts in the evaluation and treatment of all forms of common childhood and adolescent cancers. Through our Children’s Oncology Group (COG) membership, the Cancer Institute has received a prestigious Phase I clinical trial designation, making us one of only a few facilities in North America offering COG’s groundbreaking alternative treatments.
In addition to the very latest clinical trials, the Hyundai Cancer Institute is currently leading the way in pediatric cancer research. Learn more about clinical trials and our ground-breaking research studies.
